| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
Cinanserin hydrochloride manufacturers
- Cinanserin
-
- $2500.00
-
2026-07-27
- CAS:1166-34-3
- Purity:
- Supply Ability: 10g
|
| | Cinanserin hydrochloride Basic information |
| Product Name: | Cinanserin hydrochloride | | Synonyms: | N-[2-[[3-(DIMETHYLAMINO)PROPYL]THIO]PHENYL]-3-PHENYL-2-PROPENAMIDE;N-[2-[[3-(DIMETHYLAMINO)PROPYL]THIO]PHENYL]-3-PHENYL-2-PROPENAMIDE HYDROCHLORIDE;2'-(3-DIMETHYLAMINOPROPYL-THIO)-CINNAMANILIDE HYDROCHLORIDE;DPTC HYDROCHLORIDE;N-[2-[[3-(Dimethylamino)propyl]thio]phenyl]-3-phenylpropenamide;2-Propenamide, N-[2-[[3-(dimethylamino)propyl]thio]phenyl]-3-phenyl-;CINANSERIN;Cinanserine | | CAS: | 1166-34-3 | | MF: | C20H24N2OS | | MW: | 340.48 | | EINECS: | | | Product Categories: | Serotonin receptor | | Mol File: | 1166-34-3.mol |  |
| | Cinanserin hydrochloride Chemical Properties |
| Melting point | 82-83 °C | | Boiling point | 519.5±50.0 °C(Predicted) | | density | 1.13±0.1 g/cm3(Predicted) | | RTECS | UC6323000 | | storage temp. | Desiccate at RT | | solubility | Chloroform (Slightly), Methanol (Slightly) | | form | Solid | | pka | 13.46±0.70(Predicted) | | color | White to Off-White | | Water Solubility | Soluble to 50 mM in water |
| | Cinanserin hydrochloride Usage And Synthesis |
| Uses | Serotonin
inhibitor. | | Uses | A 5-HT antagonist | | Definition | ChEBI: Cinanserin is an aryl sulfide that is (2E)-3-phenyl-N-(2-sulfanylphenyl)prop-2-enamide in which the hydrogen of the thiol group is substituted by a 3-(dimethylamino)propyl group. It is a 5-hydroxytryptamine receptor antagonist and an inhibitor of SARS-CoV replication. It has a role as an EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor, an antiviral agent and an anticoronaviral agent. It is a tertiary amino compound, a secondary carboxamide, a member of cinnamamides and an aryl sulfide. It is a conjugate base of a cinanserin(1+). | | Biological Activity | 5-HT 2 antagonist. | | in vivo | Cinanserin (5 mg/kg; i.v.) treatment significantly reduces systemic burn edema levels[1]. | Animal Model: | Male Wistar rats (250 g) underwent thermal injury[1] | | Dosage: | 5 mg/kg | | Administration: | Intravenous injection; for 2 hours | | Result: | Significantly reduced systemic burn edema to shamburn levels, leukocyte-endothelial interactions are significantly reduced by administration of Cinanserin. |
| | IC 50 | 5-HT2 Receptor: 41 nM (Ki); 5-HT1 Receptor: 3500 nM (Ki); SARS-CoV 3CLpro: 49.4 μM (Kd) |
| | Cinanserin hydrochloride Preparation Products And Raw materials |
|